Αναζήτηση αυτού του ιστολογίου

Παρασκευή 16 Ιουνίου 2017

First-line Esophageal Carcinoma Study With Chemo vs. Chemo Plus Pembrolizumab (MK-3475-590/KEYNOTE-590)

Condition:   Esophageal Neoplasms
Interventions:   Biological: Pembrolizumab;   Drug: Placebo;   Drug: Cisplatin;   Drug: 5-FU
Sponsor:   Merck Sharp & Dohme Corp.
Not yet recruiting - verified June 2017

from # All Medicine by Alexandros G. Sfakianakis via ola Kala on Inoreader http://ift.tt/2rzTE15
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Exercise stereotypes and fatigue in people living with HIV: does self-efficacy play a mediating or a moderating role?

Recent research suggests that exercise stereotypes may influence physical activity through ego depletion and internalization mechanisms. The...